Status:
ACTIVE_NOT_RECRUITING
Type 2 Diabetes Remission
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
University of Manitoba
Conditions:
Type 2 Diabetes Mellitus Remission
Eligibility:
All Genders
19+ years
Brief Summary
The study aims to establish a cohort of patients with type 2 diabetes (T2D) who have achieved remission through lifestyle intervention or bariatric surgery. Remission is defined as a return of HbA1c t...
Detailed Description
The first aim of the study will be to recruit individuals (initial recruitment N=10-12 per group) with physician diagnosed T2D who have achieved remission (HbA1c less than 6.5% and absence of glucose-...
Eligibility Criteria
Inclusion
- Have previously been diagnosed with T2D;
- Have achieved diabetes remission (HbA1c below 6.5% and no glucose-lowering medications for at least 3 months) through lifestyle intervention and bariatric surgery.
Exclusion
- Have not been diagnosed with T2D;
- Have an HbA1c level higher than 6.5%;
- Are taking any glucose-lowering medications;
- Are ongoing medical treatment for diseases such as cancer, auto-immune or inflammatory disease, liver or kidney disorders;
- Are unable to follow remote guidance by internet or smartphone;
- Are unable to read or communicate in English.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06177210
Start Date
June 1 2022
End Date
August 30 2025
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia Okanagan
Kelowna, British Columbia, Canada, V1V 3G1